Clinical Trial Update: Escitalopram for the Treatment of Self-Injurious Skin Picking [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating escitalopram for self-injurious skin picking in individuals with impulse control disorders has completed. The study status is COMPLETED…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impulse Control Disorders

Drugs mentioned

• escitalopram (Lexapro) (escitalopram)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Impulse Control Disorders | Phase 4 | Status: COMPLETED